Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis

Joint Authors

Cao, Xun-Jie
Li, Ya-Ping
Xie, Li-Min
Zhang, Hong-Lang
Qin, Yu-Shan
Guo, Xu-Guang

Source

BioMed Research International

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-12, 12 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-12-01

Country of Publication

Egypt

No. of Pages

12

Main Subjects

Medicine

Abstract EN

Background.

The pathogenesis of invasive aspergillosis (IA) is still unknown, but its progression is rapid and mortality rate remains high.

Bronchoalveolar lavage fluid (BALF) galactomannan (GM) analysis has been used to diagnose IA.

This study is aimed at making an accurate estimate of the whole accuracy of BALF-GM in diagnosing IA.

Methods.

After a systematic review of the study, a bivariate meta-analysis was used to summarize the specificity (SPE), the sensitivity (SEN), the positive likelihood ratios (PLR), and the negative likelihood ratios (NLR) of BALF-GM in diagnosing IA.

The overall test performance was summarized using a layered summary receiver operating characteristic (SROC) curve.

Subgroup analysis was performed to explore the heterogeneity between studies.

Results.

A total of 65 studies that are in line with the inclusion criteria were included.

The summary estimates of BALF-GM analysis are divided into four categories.

The first is the proven+probable vs.

possible+no IA, with an SPE, 0.87 (95% CI, 0.85-0.98); SEN, 0.81 (95% CI, 0.76-0.84); PLR, 9.78 (5.78-16.56); and NLR, 0.20 (0.14-0.29).

The AUC was 0.94.

The BALF-GM test for proven+probable vs.

no IA showed SPE, 0.88 (95% CI, 0.87-0.90); SEN, 0.82 (95% CI, 0.78-0.85); PLR, 6.56 (4.93-8.75); and NLR, 0.24 (0.17-0.33).

The AUC was 0.93.

The BALF-GM test for proven+probable+possible vs.

no IA showed SPE, 0.82 (95% CI, 0.79-0.95); SEN, 0.59 (95% CI, 0.55-0.63); PLR, 3.60 (2.07-6.25); and NLR, 0.31 (0.15-0.61).

The AUC was 0.86.

The analyses for others showed SPE, 0.85 (95% CI, 0.83-0.87); SEN, 0.89 (95% CI, 0.86-0.91); PLR, 6.91 (4.67-10.22); and NLR, 0.18 (0.13-0.26).

The AUC was 0.94.

Conclusions.

The findings of this BALF-GM test resulted in some impact on the diagnosis of IA.

The BALF-GM assay is considered a method for diagnosing IA with high SEN and SPE.

However, the patients’ underlying diseases may affect the accuracy of diagnosis.

When the cutoff is greater than 1, the sensitivity will be higher.

American Psychological Association (APA)

Cao, Xun-Jie& Li, Ya-Ping& Xie, Li-Min& Zhang, Hong-Lang& Qin, Yu-Shan& Guo, Xu-Guang. 2020. Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis. BioMed Research International،Vol. 2020, no. 2020, pp.1-12.
https://search.emarefa.net/detail/BIM-1134771

Modern Language Association (MLA)

Cao, Xun-Jie…[et al.]. Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis. BioMed Research International No. 2020 (2020), pp.1-12.
https://search.emarefa.net/detail/BIM-1134771

American Medical Association (AMA)

Cao, Xun-Jie& Li, Ya-Ping& Xie, Li-Min& Zhang, Hong-Lang& Qin, Yu-Shan& Guo, Xu-Guang. Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis. BioMed Research International. 2020. Vol. 2020, no. 2020, pp.1-12.
https://search.emarefa.net/detail/BIM-1134771

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1134771